Portfolio Products by trade name   Back
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
DUOCLAV, film-coated tablets, 500 mg / 125 mg
DUOCLAV
International nonproprietary name : amoxicillin + clavulanic acid Product category : Prescription medicines (Rx) Strength : 500 mg / 125 mg Pharmaceutical form : film-coated tablets Packaging : 15 film-coated tablets Pharmacotherapeutic group :
J
ANTIINFECTIVES FOR SYSTEMIC USE
J01
ANTIBACTERIALS FOR SYSTEMIC USE
J01C
BETA-LACTAM ANTIBACTERIALS, PENICILLINS
J01CR
Combinations of penicillins, incl. beta-lactamase inhibitors
J01CR02
Amoxicillin and enzyme inhibitor
DUOCLAV, film-coated tablets, 875 mg / 125 mg
DUOCLAV
International nonproprietary name : amoxicillin + clavulanic acid Product category : Prescription medicines (Rx) Strength : 875 mg / 125 mg Pharmaceutical form : film-coated tablets Packaging : 15 film-coated tablets Pharmacotherapeutic group :
J
ANTIINFECTIVES FOR SYSTEMIC USE
J01
ANTIBACTERIALS FOR SYSTEMIC USE
J01C
BETA-LACTAM ANTIBACTERIALS, PENICILLINS
J01CR
Combinations of penicillins, incl. beta-lactamase inhibitors
J01CR02
Amoxicillin and enzyme inhibitor
DUOCLAV, powder for oral suspens ..., (400+57) mg / 5 ml
DUOCLAV
International nonproprietary name : amoxicillin + clavulanic acid Product category : Prescription medicines (Rx) Strength : (400+57) mg / 5 ml Pharmaceutical form : powder for oral suspension Packaging : 70 ml Pharmacotherapeutic group :
J
ANTIINFECTIVES FOR SYSTEMIC USE
J01
ANTIBACTERIALS FOR SYSTEMIC USE
J01C
BETA-LACTAM ANTIBACTERIALS, PENICILLINS
J01CR
Combinations of penicillins, incl. beta-lactamase inhibitors
J01CR02
Amoxicillin and enzyme inhibitor
Q&A
If you have a question about any of our products, check whether it has already been answered in the Questions and Answers section.
TAKE A LOOK AT Q&A
If you are unable to find the answer under Q&A, then send your question and one of our medical or pharmaceutical experts will answer.

prijava-icon
Newsletter
If you are a medical doctor or pharmacist, why not subscribe to our mailing list and receive the latest updates.
SUBSCRIBE
I hereby confirm that I am a medical professional*
I want to receive information and newsletters from Bosnalijek*
april 04. 2026 |
SASE |
BSNLR - Bosnalijek d.d. Sarajevo: 12,47 3,89%